Abstract
Objective:
Anemia is associated with increased cardiovascular risks. Obesity may cause anemia in several ways, for example, by low-grade inflammation and relative iron deficit. The outcomes associated with anemia in overweight/obese patients at high cardiovascular risk are however not known. Therefore, we investigated the cardiovascular prognosis in overweight/obese subjects with anemia.
Methods:
A total of 9 687 overweight/obese cardiovascular high-risk patients from the Sibutramine Cardiovascular OUTcomes trial were studied. Patients were stratified after baseline hemoglobin level and followed for the risks of primary event (comprising nonfatal myocardial infarction, nonfatal stroke, resuscitated cardiac arrest or cardiovascular death) and all-cause mortality. Risk estimates (hazard ratios (HR) with 95% confidence intervals (CI)) were calculated using Cox regression models.
Results:
Anemia was unadjusted associated with increased risk for the primary event, HR 1.73 (CI 1.37–2.18) and HR 2.02 (CI 1.34–3.06) for patients with mild or moderate-to-severe anemia, respectively, compared with patients without anemia. Adjusted for several confounders, anemia remained of prognostic importance. Increased risk of the primary events appeared to be driven by risk of cardiovascular death, adjusted HR 1.82 (CI 1.33–2.51) for mild anemia and adjusted HR 1.65 (CI 0.90–3.04) for moderate-to-severe anemia, and all-cause mortality, adjusted HR 1.50 (CI 1.17–1.93) for mild and adjusted HR 1.61 (CI 1.04–2.51) for moderate-to-severe anemia. While adding serum creatinine to the models, the increased risk of mild anemia was still a significant predictor for mortality (cardiovascular and all-cause), whereas moderate-to-severe anemia was not. For the primary events, anemia was no longer of independent prognostic importance when including serum creatinine.
Conclusion:
Anemia is associated with an increased risk of long-term adverse cardiovascular events and deaths among overweight/obese cardiovascular high-risk patients. The increased risk appeared to be driven by the risk of cardiovascular death and all-cause mortality, and renal impairments seemed to have a role in the increased risk.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Riva E, Tettamanti M, Mosconi P, Apolone G, Gandini F, Nobili A et al. Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population-based study. Haematologica 2009; 94: 22–28.
Zakai NA, Katz R, Hirsch C, Shlipak MG, Chaves PH, Newman AB et al. A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med 2005; 165: 2214–2220.
Culleton BF, Manns BJ, Zhang J, Tonelli M, Klarenbach S, Hemmelgarn BR . Impact of anemia on hospitalization and mortality in older adults. Blood 2006; 107: 3841–3846.
Dong X, Mendes de LC, Artz A, Tang Y, Shah R, Evans D . A population-based study of hemoglobin, race, and mortality in elderly persons. J Gerontol A Biol Sci Med Sci 2008; 63: 873–878.
Penninx BW, Pahor M, Woodman RC, Guralnik JM . Anemia in old age is associated with increased mortality and hospitalization. J Gerontol A Biol Sci Med Sci 2006; 61: 474–479.
Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D et al. Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 2002; 40: 27–33.
Tsujita K, Nikolsky E, Lansky AJ, Dangas G, Fahy M, Brodie BR et al. Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial). Am J Cardiol 2010; 105: 1385–1394.
Anand IS . Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 2008; 52: 501–511.
Del FP, Luthi JC, Carrera E, Michel P, Burnier M, Burnand B . Anemia and chronic kidney disease are potential risk factors for mortality in stroke patients: a historic cohort study. BMC Nephrol 2010; 11: 27.
Flegal KM, Carroll MD, Kit BK, Ogden CL . Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA 2012; 307: 491–497.
Cepeda-Lopez AC, Aeberli I, Zimmermann MB . Does obesity increase risk for iron deficiency? A review of the literature and the potential mechanisms. Int J Vitam Nutr Res 2010; 80: 263–270.
McClung JP, Karl JP . Iron deficiency and obesity: the contribution of inflammation and diminished iron absorption. Nutr Rev 2009; 67: 100–104.
Zimmermann MB, Zeder C, Muthayya S, Winichagoon P, Chaouki N, Aeberli I et al. Adiposity in women and children from transition countries predicts decreased iron absorption, iron deficiency and a reduced response to iron fortification. Int J Obes 2008; 32: 1098–1104.
Lecube A, Carrera A, Losada E, Hernandez C, Simo R, Mesa J . Iron deficiency in obese postmenopausal women. Obesity 2006; 14: 1724–1730.
Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M . Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 2004; 114: 104–108.
Lavie CJ, Milani RV, Ventura HO . Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009; 53: 1925–1932.
James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP et al. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 2010; 363: 905–917.
Verhave JC, Fesler P, Ribstein J, du CG, Mimran A . Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 2005; 46: 233–241.
Meneveau N, Schiele F, Seronde MF, Descotes-Genon V, Oettinger J, Chopard R et al. Anemia for risk assessment of patients with acute coronary syndromes. Am J Cardiol 2009; 103: 442–447.
Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005; 111: 2042–2049.
Ezekowitz JA, McAlister FA, Armstrong PW . Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003; 107: 223–225.
Charlot M, Torp-Pedersen C, Valeur N, Seibaek M, Weeke P, Kober L . Anaemia and long term mortality in heart failure patients: a retrospective study. Open Cardiovasc Med J 2010; 4: 173–177.
Tanne D, Molshatzki N, Merzeliak O, Tsabari R, Toashi M, Schwammenthal Y . Anemia status, hemoglobin concentration and outcome after acute stroke: a cohort study. BMC Neurol 2010; 10: 22.
Levy PS, Quigley RL, Gould SA . Acute dilutional anemia and critical left anterior descending coronary artery stenosis impairs end organ oxygen delivery. J Trauma 1996; 41: 416–423.
Most AS, Ruocco NA Jr., Gewirtz H . Effect of a reduction in blood viscosity on maximal myocardial oxygen delivery distal to a moderate coronary stenosis. Circulation 1986; 74: 1085–1092.
Muzzarelli S, Pfisterer M . Anemia as independent predictor of major events in elderly patients with chronic angina. Am Heart J 2006; 152: 991–996.
Ausk KJ, Ioannou GN . Is obesity associated with anemia of chronic disease? A population-based study. Obesity (Silver Spring) 2008; 16: 2356–2361.
Menzie CM, Yanoff LB, Denkinger BI, McHugh T, Sebring NG, Calis KA et al. Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc 2008; 108: 145–148.
Cepeda-Lopez AC, Osendarp SJ, Melse-Boonstra A, Aeberli I, Gonzalez-Salazar F, Feskens E et al. Sharply higher rates of iron deficiency in obese Mexican women and children are predicted by obesity-related inflammation rather than by differences in dietary iron intake. Am J Clin Nutr 2011; 93: 975–983.
Bekri S, Gual P, Anty R, Luciani N, Dahman M, Ramesh B et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006; 131: 788–796.
Tussing-Humphreys LM, Nemeth E, Fantuzzi G, Freels S, Holterman AX, Galvani C et al. Decreased serum hepcidin and improved functional iron status 6 months after restrictive bariatric surgery. Obesity 2010; 18 2010-6.
Lipsic E, van der Meer P, van Veldhuisen DJ . Erythropoiesis-stimulating agents and heart failure. Cardiovasc Ther 2011; 29: e52–e59.
Kotecha D, Ngo K, Walters JA, Manzano L, Palazzuoli A, Flather MD . Erythropoietin as a treatment of anemia in heart failure: systematic review of randomized trials. Am Heart J 2011; 161: 822–831.
McMurray JJ, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA et al. Design of the reduction of events with Darbepoetin alfa in heart failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial. Eur J Heart Fail 2009; 11: 795–801.
Singh AK . Diabetes, anemia and CKD: Why TREAT? Curr Diab Rep 2010; 10: 291–296.
Skali H, Parving HH, Parfrey PS, Burdmann EA, Lewis EF, Ivanovich P et al. Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience. Circulation 2011; 124: 2903–2908.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The co-authors Professor Finer, Professor Sharma and Professor Torp-Pedersen declare that they received consultancy fees from Abbott Laboratories as members of the SCOUT (Sibutramine Cardiovascular Outcome Trial) Executive Steering Committee until 2011. Nick Finer reports that he has received honoraria from Roche, Sanofi Avenitis and Novo Nordisk for lectures and board memberships in various drug trials. He is also a stockholder in Counterweight plc. The remaining authors declare no conflicts of interest.
Rights and permissions
About this article
Cite this article
Winther, S., Finer, N., Sharma, A. et al. Association of anemia with the risk of cardiovascular adverse events in overweight/obese patients. Int J Obes 38, 432–437 (2014). https://doi.org/10.1038/ijo.2013.111
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2013.111
Keywords
This article is cited by
-
Hemoglobin and erythrocyte count are independently and positively associated with arterial stiffness in a community-based study
Journal of Human Hypertension (2021)
-
The Impact of Intravenous Iron Supplementation on Hematinic Parameters and Erythropoietin Requirements in Hemodialysis Patients
Advances in Therapy (2021)
-
Gradient Relationship between Increased Mean Corpuscular Volume and Mortality Associated with Cerebral Ischemic Stroke and Ischemic Heart Disease: A Longitudinal Study on 66,294 Taiwanese
Scientific Reports (2018)
-
Anemia in the general population: prevalence, clinical correlates and prognostic impact
European Journal of Epidemiology (2014)